M. Shizuka

发表

Cerebrospinal fluid tau in dementia disorders

E. Matsubara, M. Shoji, K. Okamoto, 2000, Neurobiology of Aging.

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

A. Monaco, M. Brin, J. Volkmann, 2002, European Journal of Human Genetics.

S. Hirai, E. Matsubara, M. Shoji, 2000, The Journal of pathology.

Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy

S. Hirai, E. Matsubara, M. Shoji, 2000, Journal of neurology, neurosurgery, and psychiatry.

Molecular analysis of a de novo mutation for spinocerebellar ataxia type 6 and (CAG)n repeat units in normal elder controls

M. Shoji, K. Okamoto, Mitsunori Watanabe, 1998, Journal of the Neurological Sciences.

Deletion and nonsense mutations of the connexin 32 gene associated with Charcot-Marie-Tooth disease.

M. Shoji, K. Hayasaka, G. Nicholson, 1999, The Tohoku journal of experimental medicine.

Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, γ‐globulin, and α‐fetoprotein

M. Koenig, M. Shoji, K. Okamoto, 1998 .

Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.

M. Koenig, M. Shoji, M. Watanabe, 1998, Annals of neurology.

Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan

K. Okamoto, Mitsunori Watanabe, Y. Ikeda, 2000, Neurology.

Homozygosity mapping of spinocerebellar ataxia with cerebellar atrophy and peripheral neuropathy to 9q33–34, and with hearing impairment and optic atrophy to 6p21–23

M. Koenig, M. Watanabe, M. Shizuka, 2000, European Journal of Human Genetics.

Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains.

P. S. St George-Hyslop, S. Hirai, E. Matsubara, 1999, Biochemical and biophysical research communications.

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

S. Hirai, T. Iwatsubo, K. Nakashima, 1998 .

Analysis of the McLeod syndrome gene in three patients with neuroacanthocytosis

Y. Itoyama, M. Shoji, K. Okamoto, 1997, Journal of the Neurological Sciences.

A novel mutation of the myelin P0 gene segregating Charcot-Marie-Tooth disease type 1B manifesting as trigeminal nerve thickening

M. Shoji, M. Watanabe, K. Okamoto, 1999, Journal of neurology, neurosurgery, and psychiatry.

Accumulation of Amyloid β Protein in Transgenic Mice

S. Hirai, E. Matsubara, M. Shoji, 1998, Neurobiology of Aging.

Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease

E. Matsubara, M. Shoji, K. Urakami, 1999, Neuroscience Letters.

Title : Apolipoprotein E 4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer ' s disease

E. Matsubara, M. Shoji, K. Urakami, 1999 .

The levels of cerebrospinal fluid Aβ40 and Aβ42(43) are regulated age-dependently

S. Hirai, E. Matsubara, M. Shoji, 2001, Neurobiology of Aging.

Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease

S. Hirai, E. Matsubara, M. Shoji, 1998, Journal of the Neurological Sciences.

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

S. Hirai, T. Iwatsubo, K. Nakashima, 1998, Annals of neurology.

Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group

S. Hirai, K. Nakashima, H. Arai, 2002, Neurobiology of Aging.

Mitotic and meiotic stability of the CAG repeat in the X‐linked spinal and bulbar muscular atrophy gene

Y. Itoyama, S. Hirai, M. Shoji, 1996, Clinical genetics.

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

S. Hirai, E. Matsubara, M. Shoji, 1998, Journal of the neurological sciences.

[Sensory ataxic neuropathy presenting anti-a-fodrin antibody associated with rheumatoid arthritis].

K. Okamoto, M. Shizuka, Y. Hayashi, 1999, Rinsho shinkeigaku = Clinical neurology.

Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics

Y. Itoyama, M. Shoji, K. Okamoto, 1998, Journal of the Neurological Sciences.

Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis: (CCG)1- 2 polymorphism and contribution to founder effect

M. Shoji, K. Okamoto, Mitsunori Watanabe, 1999, Journal of medical genetics.

The levels of cerebrospinal fluid Abeta40 and Abeta42(43) are regulated age-dependently.

S. Hirai, E. Matsubara, M. Shoji, 2001, Neurobiology of Aging.

Analysis of spinocerebellar ataxia type 2 gene and haplotype analysis: (CCG)1- 2 polymorphism and contribution to founder effect

M. Shoji, K. Okamoto, I. Kondo, 1999, Journal of medical genetics.